these can include pain, redness, or swelling at the site of the shot, which typically resolve on their own
Vukusic D et al
Clinical Status: BPC-157 is a research peptide evaluated in numerous animal models and limited human observational studies for gastrointestinal healing, musculoskeletal regeneration, and angiogenic modulation
The inclusion of KPV in the Category 2 list under the FDA peptide regulations 2026 highlights the agency's cautious approach to peptides used for systemic inflammation
Bacteriostatic 0.9% Sodium Chloride Injection, USP is a sterile, non-pyrogenic, isotonic solution of
BPC-157 actively reduces inflammation throughout the body, making it an excellent treatment for conditions like tendonitis, arthritis, and overuse injuries